Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Karen Kelly, John Crowley, Paul A. Bunn et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer

Jan P. Neijt, Svend Aage Engelholm, Malgorzata Tuxen et al. · Journal of Clinical Oncology · 2000 · 441 citations

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

Eric K. Rowinsky, Mark R. Gilbert, William P. McGuire et al. · Journal of Clinical Oncology · 1991 · 431 citations

Hematological Malignancy, Molecular Pharmacology, Dosage Permutations +15

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

J.T. Thigpen, John A. Blessing, Harrison Ball et al. · Journal of Clinical Oncology · 1994 · 389 citations

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

A. Y. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute · 1993 · 339 citations